1. Home
  2. AKAN vs NXTS Comparison

AKAN vs NXTS Comparison

Compare AKAN & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akanda Corp.

AKAN

Akanda Corp.

HOLD

Current Price

$2.79

Market Cap

2.0M

Sector

Health Care

ML Signal

HOLD

Logo Nexentis Technologies Inc. Common Stock

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$1.56

Market Cap

2.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
AKAN
NXTS
Founded
2021
2009
Country
Canada
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
2.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
AKAN
NXTS
Price
$2.79
$1.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
520.3K
16.2K
Earning Date
05-12-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$263,445.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$0.55
52 Week High
$78.90
$23.80

Technical Indicators

Market Signals
Indicator
AKAN
NXTS
Relative Strength Index (RSI) 30.80 35.76
Support Level $0.67 $1.43
Resistance Level $3.40 $2.08
Average True Range (ATR) 0.46 0.13
MACD 0.10 0.02
Stochastic Oscillator 1.58 9.00

Price Performance

Historical Comparison
AKAN
NXTS

About AKAN Akanda Corp.

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company is a medical cannabis & hemp and wellness platform company seeking to help people lives through improved access to high-quality and affordable products. The Company is also in the business of leasing fiber optic networks and telecommunication towers, through its subsidiary. The company has four reportable segments: Infrastructure, Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Infrastructure segment, which relates to the leasing and/or rental of fiber optic networks and telecommunication towers at First Towers in Mexico.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: